Therefore, we hypothesized that the relief of cell apoptosis in the UC-MSCs-IGF-1 group was mainly due to the therapeutic action of overexpressed IGF-1 against AKI, or the secondary effect of the enhanced anti-oxidation capacity and the anti-inflammatory capacity. This evidence concerns the gene IGF1 and acute kidney injury.